Michael Goodwin, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1140 Lexington Rd, Georgetown, KY 40324 Phone: 502-868-1100 |
Anthony Jay Lopez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1140 Lexington Rd, Georgetown, KY 40324 Phone: 502-868-1100 |
Raymond Depa, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1140 Lexington Rd, Georgetown, KY 40324 Phone: 502-868-1100 |
Edward J Ziembroski, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1140 Lexington Road, Georgetown, KY 40324 Phone: 502-868-1100 |
Nadia Rasheed, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1140 Lexington Rd, Georgetown, KY 40324 Phone: 502-868-1100 |
Paul Skinner, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1140 Lexington Rd, Georgetown, KY 40324 Phone: 502-868-1100 |
News Archive
Our cells live ever on the verge of suicide, requiring the close attention of a team of molecules to prevent the cells from pulling the trigger. This self-destructive tendency can be a very good thing, as when dangerous precancerous cells are permitted to kill themselves, but it can also go horribly wrong, destroying brain cells that store memories, for instance. Rockefeller University scientists are parsing this perilous arrangement in ever finer detail in hopes that understanding the basic mechanisms of programmed cell death, or apoptosis, will enable them eventually to manipulate the process to kill the cells we want to kill and protect the ones we don't.
Researchers at UCLA's California NanoSystems Institute, the David Geffen School of Medicine at UCLA and the Howard Hughes Medical Institute have modeled the structure of the largest cellular particle ever crystallized, suggesting ways to engineer the particles for drug delivery.
Dendreon Corporation today announced the presentation of safety data from the integrated analysis of four randomized PROVENGE® (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in prostate cancer at the 105th Annual Scientific Meeting of the American Urological Association (AUA) in San Francisco.
A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2019 Annual Meeting.
More and more opioids are being prescribed for pain relief in Germany. This is the conclusion arrived at by Ingrid Schubert, Peter Ihle, and Rainer Sabatowski, whose study of a sample of inhabitants of the state of Hesse with health insurance from a large statutory provider is published in the latest issue of Deutsches Ärzteblatt International.
› Verified 7 days ago